Research

What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.

365 Articles

Dr. Zev Wainberg
Research
July 28, 2020 • 4 Min

NALIRIFOX Shows Promise in Early Studies

Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.

Dr. Jennifer Knox
Research
July 15, 2020 • 6 Min

Canadian Study NeoPancONE Focuses on Biomarker Validation

Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.

Image of a cancer drug target visualized at the atomic level
Research
July 7, 2020 • 2 Min

Slowing the Spread of Advanced Pancreatic Cancer

Researchers are testing a kinase inhibitor that is used to treat lung diseases, including a type of lung cancer, against pancreatic cancer.

Dr. Sapna Syngal
Research
July 2, 2020 • 4 Min

GENERATE Trial Expands Eligibility

Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.

Dr. Daniel Holzwanger
Research
June 19, 2020 • 5 Min

DIRECT Study Focuses on NanoKnife Technology

Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.

red tops and black tops of new beakers against a silver background
Research
June 11, 2020 • 3 Min

Chemotherapy Plus Minimally Invasive Surgery for Pancreatic Cancer

Researchers want to know if irreversible electroporation (IRE) makes it easier for chemotherapy to reach pancreatic cancer cells.

Dr. Jordan Winter
Research
June 8, 2020 • 6 Min

Targeting Metabolic Vulnerability

Dr. Jordan Winter looks at cell metabolism to find areas of vulnerability in pancreatic cancer cells, to find a way to create better treatments.

Dr. Manuel Hidalgo
Research
May 26, 2020 • 5 Min

COMBATing Pancreatic Cancer

Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.

Fractal flame ribbons in whte and red on a black background
Research
May 15, 2020 • 2 Min

Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer

Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.

Dino Verrelli and Dr. Diane Simeone
Research
May 12, 2020 • 7 Min

Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint

Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.

Dr. Manish Shah
Research
April 29, 2020 • 5 Min

High-Dose Vitamin C Targeting KRAS and BRAF in Pancreatic Cancer

Learn how Dr. Manish Shah is leading clinical trials using high-dose Vitamin C to target KRAS and BRAF mutations in pancreatic cancer.

Test tubes in a gold test tube holder
Research
April 21, 2020 • 2 Min

Testing a Drug that Works Only in the Tumor Microenvironment

Scientists are trying a new type of drug combination that gets activated only in the unique conditions of the tumor microenvironment.

Dr. Beatriz Carreno
Research
April 16, 2020 • 5 Min

Targeting Mutant KRAS with Immunotherapy

Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

PanCAN CSO Lynn Matrisian
Research
April 3, 2020 • 5 Min

Tumor Biology Matters

Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.

The tops of closed lab vials as seen from overhead against a blue-ish background
Research
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.